Health ❯ Public Health

Obesity

Weight Management Childhood Obesity Nutrition Weight Loss Treatment Statistics Epidemiology Health Risks Causes of Obesity Prevention Diabetes Treatment Options Dietary Habits Chronic Diseases Child Health Body Mass Index Medications Health Policy Demographics Weight Loss Drugs Prevalence Economic Impact Causes Adolescent Health Dietary Guidelines Metabolic Disorders Dietary Recommendations Diagnosis Diet-related Diseases Dietary Interventions Treatment Guidelines Health Initiatives Societal Impact Government Initiatives Genetics Prevention Strategies Obesity Treatment Mental Health Lifestyle Diseases Dietary Impact Health Campaigns Youth Obesity Drug Development Risk Factors Chronic Conditions Obesity Rates Global Trends Weight Loss Strategies Disability Benefits Dietary Issues Cancer Health Disparities Research Health Policies Weight Loss Treatments Trends Dietary Choices Health Implications Obesity Classification Cardiovascular Disease Anti-Obesity Medications Cardiovascular Health Obesity-Related Health Issues Pandemic Effects Body Mass Index (BMI) Treatment Strategies Global Obesity Global Obesity Rates Stigma Clinical Trials Global Obesity Crisis Policy Interventions Chronic Illness Medication Global Impact Anti-Obesity Drugs Social Implications Exercise Policy Solutions Neuroscience Global Obesity Trends Global Obesity Statistics Food Choices Health Statistics Weight Loss Medication Heart Disease Weight Loss Medications Obesity in the U.S. Biological Aging Visceral Obesity Severe Obesity Obesity Trends Child Obesity Government Intervention Vascular Health Nutritional Information Nutrition Policy Government Programs Dietary Changes Healthcare

JAMA Forecast: Nearly Half of U.S. Adults Could Have Obesity by 2035

Researchers say the BMI-based, pre‑2023 dataset limits confidence in the forecast.

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Genetic Study Links Higher BMI and Blood Pressure to Causal Risk of Vascular-Related Dementia

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

U.S. Unveils Protein‑First Dietary Guidelines, Replacing MyPlate With Inverted Pyramid

Review Warns Food Systems Alone Could Exceed Paris Warming Limits

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Rubio Orders Visa Officers to Weigh Obesity and Chronic Illness Under Public‑Charge Rule

Childhood Hypertension Nearly Doubled Worldwide Since 2000, Global Review Finds

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

CMS Chief Mehmet Oz Urges ‘Trump Babies’ Before 2026 at Oval Office Drug-Pricing Event

Shopping Data Maps London’s Food Deserts, Challenging Store-Access Assumptions

WalletHub 2025 Ranking Puts West Virginia Most Overweight, Colorado Lowest

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds

Uber Rider’s Viral Video Alleges Weight-Based Refusal and Gun Threat